1. A Novel Nanobody Precisely Visualizes Phosphorylated Histone H2AX in Living Cancer Cells under Drug-Induced Replication Stress
- Author
-
Jeremy Ranniger, Pascal Didier, Manuela Chiper, Gabrielle Zeder-Lutz, Christian Massute, Barbara Di Ventura, Mustapha Oulad-Abdelghani, Eric Moeglin, Arnaud Poterszman, Alastair G. McEwen, Pierre Lafaye, Audrey Stoessel, Dominique Desplancq, Etienne Weiss, Biotechnologie et signalisation cellulaire (BSC), Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Institut de recherche de l'Ecole de biotechnologie de Strasbourg (IREBS), University of Freiburg [Freiburg], Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Ingénierie des Anticorps (plate-forme) - Antibody Engineering (Platform), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Bioimagerie et Pathologies (LBP), Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS), This work was supported by EUCOR-The European Campus (Seed Money #22), the Ligue Régionale contre le Cancer (Comité du Haut-Rhin), the French Infrastructure for Integrated Structural Biology FRISBI (ANR-10-INBS-05), the Instruct-ERIC and Instruct-ULTRA infrastructure of EU Horizon 2020 (grant ID 731005), the Centre National de la Recherche Scientifique (CNRS), the Deutsche Forschungsgemeinschaft (DFG) under Germany’s Excellence Strategy through EXC294 (BIOSS—Center for Biological Signalling Studies) and EXC2189 (CIBSS—Centre for Integrative Biological Signalling Studies, Project ID 390939984), and the Universities of Strasbourg and Freiburg. E.M. was founded by a MENESR fellowship., ANR-10-INBS-0005,FRISBI,Infrastructure Française pour la Biologie Structurale Intégrée(2010), European Project: 731005,H2020-INFRADEV-2016-1,INSTRUCT-ULTRA(2017), Université de Strasbourg (UNISTRA)-Institut de recherche de l'Ecole de biotechnologie de Strasbourg (IREBS)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), POTERSZMAN, Arnaud, Infrastructure Française pour la Biologie Structurale Intégrée - - FRISBI2010 - ANR-10-INBS-0005 - INBS - VALID, and Releasing the full potential of Instruct to expand and consolidate infrastructure services for integrated structural life science research - INSTRUCT-ULTRA - - H2020-INFRADEV-2016-12017-01-01 - 2020-12-31 - 731005 - VALID
- Subjects
0301 basic medicine ,Cancer Research ,Phage display ,DNA damage ,replication stress ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,Transduction (genetics) ,0302 clinical medicine ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,one-step detection ,[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology ,H2AX ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Sciences du Vivant [q-bio]/Immunologie ,RC254-282 ,Phosphorylated Histone H2AX ,phosphorylation ,Histone H2AX ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,imaging ,Fusion protein ,genotoxicity assay in live cells ,3. Good health ,Cell biology ,nanobody ,030104 developmental biology ,Oncology ,chemistry ,030220 oncology & carcinogenesis ,Cancer cell ,cancer cells ,DNA - Abstract
Simple Summary γ-H2AX, a phosphorylated variant of histone H2A, is a widely used biomarker of DNA replication stress. To develop an immunological probe able to detect and track γ-H2AX in live cancer cells, we have isolated single domain antibodies (called nanobodies) that are easily expressed as functional recombinant proteins and here we report the extensive characterization of a novel nanobody that specifically recognizes γ-H2AX. The interaction of this nanobody with the C-terminal end of γ-H2AX was determined by X-ray crystallography. Moreover, the generation of a bivalent nanobody allowed us to precisely detect γ-H2AX foci in drug-treated cells as efficiently as with commercially available conventional antibodies. Furthermore, we tracked γ-H2AX foci in live cells upon intracellular delivery of the bivalent nanobody fused to the red fluorescent protein dTomato, making, consequently, this new cost-effective reagent useful for studying drug-induced replication stress in both fixed and living cancer cells. Abstract Histone H2AX phosphorylated at serine 139 (γ-H2AX) is a hallmark of DNA damage, signaling the presence of DNA double-strand breaks and global replication stress in mammalian cells. While γ-H2AX can be visualized with antibodies in fixed cells, its detection in living cells was so far not possible. Here, we used immune libraries and phage display to isolate nanobodies that specifically bind to γ-H2AX. We solved the crystal structure of the most soluble nanobody in complex with the phosphopeptide corresponding to the C-terminus of γ-H2AX and show the atomic constituents behind its specificity. We engineered a bivalent version of this nanobody and show that bivalency is essential to quantitatively visualize γ-H2AX in fixed drug-treated cells. After labelling with a chemical fluorophore, we were able to detect γ-H2AX in a single-step assay with the same sensitivity as with validated antibodies. Moreover, we produced fluorescent nanobody-dTomato fusion proteins and applied a transduction strategy to visualize with precision γ-H2AX foci present in intact living cells following drug treatment. Together, this novel tool allows performing fast screenings of genotoxic drugs and enables to study the dynamics of this particular chromatin modification in individual cancer cells under a variety of conditions.
- Published
- 2021
- Full Text
- View/download PDF